GDP Issues cited in Non-Compliance Report
Register now for ECA's GMP Newsletter
A new Non-Compliance Report was published on the EudraGMDP site. On 21 September 2017, the Danish Medicines Agency performed an inspection at EuroPharma.DK ApS in Denmark. EuroPharma.DK ApS performs parallel import, repacking and distribution of pharmaceutical products.
During that inspection, it was considered that the secondary packing operations at the site do not comply with Good Manufacturing Practice and that there is a "lack of will and ability to adhere to the principles" of Good Distribution Practices (GDP):
This was also based on the following observations:
- Inadequate control for falsifications and temperature excursions during transportation upon receipt of medicinal products
- Deficient procedures for qualification of transporters/forwarders
As a consequence, the respective manufacturing authorisation was suspended and medicinal products must not be re-packed by EuroPharma DK or any of their contract manufacturers and must not be released and distributed.
Source: EudraGMDP Database (Non-Compliance Reports, Report No: 2017090955)
Related GMP News
14.10.2025MHRA Blog Post: GDP in the Aviation and Marine Sectors
14.10.2025Commercial GDP Certificates: Helpful Tool or Questionable Assurance?
14.10.2025Mean Kinetic Temperature (MKT): Calculation, Benefits, and Limitations
14.10.2025Fiscal Importation within the EEA - Discussion of ECA GDP Survey Results
16.09.2025BioPhorum Survey on -40 °C Drug Substance Storage Practices